News & Articles

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel

Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States

Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients

Watch this webinar on demand to learn about the host immune response to COVID-19

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need